Sandoz Will Wait A Decade On Amantadine

Patent-Litigation Settlement Permits 2030 Launch

Target_2030
Sandoz has agreed to wait until 2030 to launch a generic of Gocovri in the US • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin